{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:45:48Z","timestamp":1795023948550,"version":"4.10.2"},"reference-count":45,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The associations between triglyceride glucose (TyG), triglyceride glucose-body mass index (TyG-BMI), and non-alcoholic fatty liver disease (NAFLD) in high-altitude regions remain unclear. Methods: This is a cross-sectional, population-based study comprising 1384 adults living in Jianchuan county, China, which has an average altitude of over 2200 m. Logistic regressions were used to examine the associations between TyG, TyG-BMI, and NAFLD. Receiver operating characteristic (ROC) curves were utilized to compare the predictive ability of TyG, TyG-BMI, hepatic steatosis index (HSI), and triglyceride glucose-alanine aminotransferase (TyG-ALT). Results: In total, 307 (35.7%) male and 81 (15.4%) female participants were diagnosed with NAFLD. Individuals with NAFLD had higher BMI, blood pressure, and TyG indices. The adjusted odds ratios (95% confidence intervals) for the highest quartile of TyG and TyG-BMI were 16.04 (8.51\u201330.25) and 48.55 (25.12\u201393.81), respectively. The areas under the ROC curve were 0.811 (95% CI: 0.787\u20130.836) for TyG, 0.883 (95% CI: 0.864\u20130.902) for TyG-BMI, 0.839 (95% CI: 0.817\u20130.863) for HSI, and 0.831 (95% CI: 0.801\u20130.855) for TyG-ALT. Tyg-BMI had the highest sensitivity (0.832) and specificity (0.780) compared to the other indices. Conclusions: Both TyG and TyG-BMI were associated with higher NAFLD risk in people living in high-altitude regions, while TyG-BMI had greater predictive capabilities.<\/jats:p>","DOI":"10.3390\/jcm13237423","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T09:30:18Z","timestamp":1733391018000},"page":"7423","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predictive Value of TyG and TyG-BMI Indices for Non-Alcoholic Fatty Liver Disease in High-Altitude Regions of China: A Cross-Sectional Study"],"prefix":"10.3390","volume":"13","author":[{"given":"Xuejie","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"},{"name":"Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenni","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"},{"name":"Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease-A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus-mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","year":"2008","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","article-title":"Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101345","DOI":"10.1016\/j.diabet.2022.101345","article-title":"The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients","volume":"48","author":"Jaussent","year":"2022","journal-title":"Diabetes Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5121574","DOI":"10.1155\/2019\/5121574","article-title":"The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study","volume":"2019","author":"Kitae","year":"2019","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/met.2020.0109","article-title":"Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight\/Obesity","volume":"19","author":"Khamseh","year":"2021","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","article-title":"The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease","volume":"20","author":"Sheng","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e075413","DOI":"10.1136\/bmjopen-2023-075413","article-title":"Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: A cross-sectional study","volume":"13","author":"Yu","year":"2023","journal-title":"BMJ Open"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Song, K., Lee, H.W., Choi, H.S., Park, G., Lee, H.S., Kim, S.J., Lee, M., Suh, J., Kwon, A., and Kim, H.-S. (2022). Comparison of the Modified TyG Indices and Other Parameters to Predict Non-Alcoholic Fatty Liver Disease in Youth. Biology, 11.","DOI":"10.3390\/biology11050685"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41569-023-00924-9","article-title":"Cardiovascular physiology and pathophysiology at high altitude","volume":"21","author":"Richalet","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"117633","DOI":"10.1016\/j.lfs.2020.117633","article-title":"High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling","volume":"252","author":"Song","year":"2020","journal-title":"Life Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lopez-Pascual, A., Ar\u00e9valo, J., Mart\u00ednez, J.A., and Gonz\u00e1lez-Muniesa, P. (2018). Inverse Association Between Metabolic Syndrome and Altitude: A Cross-Sectional Study in an Adult Population of Ecuador. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00658"},{"key":"ref_16","unstructured":"(2019, January 01). Jianchuan County. Available online: https:\/\/www.tripchinaguide.com\/attraction-p225-jianchuan-county.html."},{"key":"ref_17","first-page":"1212","article-title":"Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies","volume":"11","author":"Reinshagen","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40200-021-00941-w","article-title":"The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): A population-based study among Iranian adults","volume":"21","author":"Taheri","year":"2022","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liao, Y., Wang, L., Liu, F., Zhou, Y., Lin, X., Zhao, Z., Xu, S., Tang, D., Jiao, Y., and Yang, L. (2023). Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1078149"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Petzold, G. (2022). Role of Ultrasound Methods for the Assessment of NAFLD. J. Clin. Med., 11.","DOI":"10.3390\/jcm11154581"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1159\/000484105","article-title":"Quantitative Renal Echogenicity as a Tool for Diagnosis of Advanced Chronic Kidney Disease in Patients with Glomerulopathies and no Liver Disease","volume":"42","author":"Leite","year":"2017","journal-title":"Kidney Blood Press. Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2021). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142022. Diabetes Care, 45, S17\u2013S38.","DOI":"10.2337\/dc22-S002"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2021.01.019","article-title":"Hypertension in NAFLD: An uncontrolled burden","volume":"74","author":"Kasper","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41182-020-00289-6","article-title":"Unique hemoglobin dynamics in female Tibetan highlanders","volume":"49","author":"Arima","year":"2021","journal-title":"Trop. Med. Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: Landscape and limitations","volume":"21","author":"Tao","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","article-title":"Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients","volume":"19","author":"Alizargar","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","article-title":"The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: Evidence from NHANES 2001\u20132018","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/MEG.0000000000002806","article-title":"Assessment of the clinical value of five noninvasive predictors of metabolic dysfunction-associated steatotic liver disease in Han Chinese adults","volume":"36","author":"Ma","year":"2024","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"102400","DOI":"10.1016\/j.clinre.2024.102400","article-title":"Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort","volume":"48","author":"Velasco","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12944-023-01954-5","article-title":"Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease","volume":"22","author":"Wang","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/ijcp.12756","article-title":"Cardiometabolic risk factors in native populations living at high altitudes","volume":"70","author":"Hirschler","year":"2016","journal-title":"Int. J. Clin. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"D\u00fcnnwald, T., Gatterer, H., Faulhaber, M., Arvandi, M., and Schobersberger, W. (2019). Body Composition and Body Weight Changes at Different Altitude Levels: A Systematic Review and Meta-Analysis. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.00430"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Li, D., Zhang, M., Wu, S., Tan, H., and Li, N. (2022). Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-17511-6"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, J., Yan, S., Cui, Y., Chen, F., Piao, M., and Cui, W. (2022). The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis. Nutrients, 14.","DOI":"10.3390\/nu14234969"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Song, S., Son, D.H., Baik, S.J., Cho, W.J., and Lee, Y.J. (2022). Triglyceride Glucose-Waist Circumference (TyG-WC) Is a Reliable Marker to Predict Non-Alcoholic Fatty Liver Disease. Biomedicines, 10.","DOI":"10.21203\/rs.3.rs-1216056\/v1"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12967-022-03611-4","article-title":"The triglyceride glucose-body mass index: A non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population","volume":"20","author":"Hu","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: From obesity to metabolic syndrome and diabetes","volume":"12","author":"Valerio","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/dom.14322","article-title":"Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review","volume":"23","author":"Cariou","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_40","first-page":"940","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications","volume":"74","author":"Francque","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4093\/dmj.2020.0010","article-title":"Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association","volume":"44","author":"Lee","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"ref_42","first-page":"230","article-title":"Emerging Molecular Mechanisms of NAFLD in the Context of Metabolic Dysfunction","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_44","first-page":"7","article-title":"Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: An updated meta-analysis of observational studies","volume":"1","author":"Stefano","year":"2021","journal-title":"Metab. Target Organ Damage"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7423\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:47:54Z","timestamp":1760114874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":45,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13237423"],"URL":"https:\/\/doi.org\/10.3390\/jcm13237423","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]}}}